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Abstract
Background: Infantile colic is a common disturb within the first 3 months of life, nevertheless the pathogenesis is
incompletely understood and treatment remains an open issue. Intestinal gas production is thought to be one of
the causes of abdominal discomfort in infants suffering from colic. However, data about the role of the amount of
gas produced by infants’ colonic microbiota and the correlation with the onset of colic symptoms are scanty. The
benefit of supplementation with lactobacilli been recently reported but the mechanisms by which they exert their
effects have not yet been fully defined. This study was performed to evaluate the interaction between Lactobacillus
spp. strains and gas-forming coliforms isolated from stools of colicky infants.
Results: Strains of coliforms were isolated from stools of 45 colicky and 42 control breastfed infants in McConkey Agar
and identified using PCR with species-specific primers, and the BBL™ Enterotube™ II system for Enterobacteriaceae.
Gas-forming capability of coliforms was assessed in liquid cultures containing lactose as sole carbon source. The
average count of total coliforms in colicky infants was significantly higher than controls: 5.98 (2.00-8.76) log10 vs 3.90
(2.50-7.10) CFU/g of faeces (p = 0.015). The following strains were identified: Escherichia coli, Klebsiella pneumoniae,
Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter cloacae and Enterococcus faecalis.T h e n ,2 7Lactobacillus strains
were tested for their antagonistic effect against coliforms both by halo-forming method and in liquid co-cultures.
Lactobacillus delbrueckii subsp.delbrueckii DSM 20074 and L. plantarum MB 456 were able to inhibit all coliforms strains
(halo-forming method), also in liquid co-cultures, thus demonstrating an antagonistic activity.
Conclusions: This study shows that two out of 27 strains of Lactobacillus examined possess an antimicrobial effect
against six species of gas-forming coliforms isolated from colicky infants. Our findings may stimulate new
researches to identify which Lactobacillus strains can improve colicky symptoms by acting on coliforms gut
colonization.
Background
T h ei n t e s t i n a lm i c r o b i o t ae x e r t sm a n yp h y s i o l o g i c a l
functions such as metabolic and trophic activities and
plays an important role in the “barrier effect” against
exogenous microbes [1]. It is also involved in the devel-
opment and activation of the intestinal immune system:
a recent study suggests that a more diverse gut micro-
biota early in life might prevent allergy development [2].
Gut microbiota is acquired during early life and
intestinal colonization starts immediately after birth.
The ability of species to establish themselves durably in
the colonic ecosystem depends on complex interactions
between host and bacteria as well as between the bac-
teria themselves [3]. A wide range of factors may influ-
ence the establishment of the intestinal microbiota,
including type of delivery, feeding pattern, antibiotic
therapy, contact with parents, siblings and hospital staff
[4]. The nature of the gut flora, colonic bacterial meta-
bolic pathways, the partial pressure of hydrogen in the
colon, the buffering capacity of the colon, and incom-
plete monosaccharide absorption may play a part in
infantile colic. Miller reported an increased breath
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colic [5]. In 1994, Lehtonen et al. o b s e r v e dt h a ta n
inadequate lactobacilli level occurring in the first
months of life may affect the intestinal fatty acids profile
and could favour the development of infantile colic [6].
Treem suggested that colicky infants produce large
amounts of gas probably by colonic bacterial fermenta-
tion of malabsorbed dietary carbohydrate and that they
are relieved of symptoms by the passage of gas [7]. It
has also been demonstrated that less methane is pro-
duced by stool of colicky infants and this could be due
to an inability of the gut microbiota to convert hydrogen
to methane with a gastrointestinal hydrogen accumula-
tion [8]. Moreover few old data support the notion that
colicky infants produce more breath hydrogen in the
fasting state and in response to feedings, which is
thought to be evidence of lactose intolerance [9-11].
Differences in gut microbiota have been found among
colicky and non-colicky infants: colicky infants are less fre-
quently colonized by Lactobacillus spp. and more fre-
quently by anaerobic gram-negative bacteria [12]. Further,
different colonization patterns of lactobacilli have been
found among colicky and healthy infants: L. brevis and L.
lactis are present only in colicky infants while L. acidophi-
lus was detected only in healthy ones [13].
The recent finding that L. reuteri improve colic symp-
toms in breastfed infants suggested that a peculiar com-
position of the intestinal microbiota could favour the
development of such disturbance [14,15]; however the
mechanisms through which lactic acid bacteria act on
colic symptoms remain speculative. Moreover, our
recent study evaluated the colonization pattern of some
important gas-forming coliforms in colicky infants and
healthy controls through molecular methods: coliform
bacteria, in particular Escherichia coli,r e s u l t e dm o r e
abundant in infants with infantile colic, reinforcing the
concept that gut microbiota could be implicated in the
aetiopathogenesis of the disturbance [16,17]. Neverthe-
less, up today, little is known about the role of the
amount of gas produced by infants’ colonic microbiota
and the correlation with the onset of colic symptoms,
even thought intestinal gas is though to be one of the
causes of abdominal discomfort.
This study was performed to elucidate the interaction
between lactobacilli and gas-forming coliforms in the
gut. To this aim, 27 Lactobacillus strains were examined
for their potential in-vitro anti-microbial activity against
gas-forming coliforms isolated from stools of colicky
infants.
Methods
Study group and sample collection
Forty-five breastfed infants suffering from colic symp-
toms and 42 control breastfed infants (i.e. non colicky)
were recruited at the Department of Pediatrics - Regina
Margherita Children Hospital, Turin, Italy. They were
all aged between 4 and 12 weeks, adequate for gesta-
tional age, with a birth weight in the range 2500 and
4000 g, without clinical evidence of chronic illness or
gastrointestinal disorders or previous administration of
antibiotics and probiotics in the week preceding recruit-
ment. The characteristics of colicky and control subjects
are shown in Table 1. Only exclusively breastfed infants
were enrolled in order to reduce variability in the intest-
inal microflora and in the colonic gas associated with
dietary variations [18,19]. The colicky cry was defined as
a distinctive pain cry difficult to console, lasted for 3
hours or more per day on 3 days or more per week,
diagnosed according Wessel criteria [20], with debut 6 ±
1 days before the enrolment. At the enrolment each
subject underwent a medical examination and parents
were interviewed in order to obtain background data
concerning type of delivery, birth weight and gestational
age, family history of gastrointestinal disease and atopy.
Parents gave written consent to the inclusion of their
infants in the study. About 5-10 g faeces were collected
from both colicky and non-colicky infants, stored at -
80°C immediately after collection and subsequently pro-
cessed. The study was approved by the local ethic com-
mittee (Comitato Interaziendale AA.SS.OO. O.I.R.M./S.
Anna-Ordine Mauriziano di Torino).
Isolation and identification of coliforms
Faecal samples, collected from all infants, were homoge-
nized (10%, w/v) with sterile saline (0.9% NaCl). The
homogenates were filtered through a 100 μm metal sieve
and serially diluted in saline. One hundred μlo fe a c hd i l u -
tion were plated on selective MacConkey Agar (BD Italia,
Milan, Italy), which is widely used to isolate enteric bac-
teria and as a presumptive test for coliform organisms [21]
and plates were incubated overnight at 37°C in 5% CO2
atmosphere. All colonies were counted and counts
expressed as log10 colony-forming units (CFU) per g of
faeces. Each isolated strain was subcultured at 37°C for 18
h in Luria Bertani medium (LB) [22] under microaerophi-
lic conditions. Identification of the isolated strains was
performed by using the polymerase chain reaction (PCR)
technique followed by sequencing of the amplified
sequences and the BBL™ Enterotube™ II system, which
allows the identification of Enterobacteriaceae on the basis
of selective carbohydrate fermentation, gas production and
the response to selective biochemical reactions (Becton
Dickinson GmbH, Heidelberg, Germany). PCR was per-
formed as follows: each isolated strain was streaked on a
LB plate, which was incubated overnight at 37°C. A single
colony of each strain was picked and suspended in 20 μl
of sterile distilled water; the cell suspension was heated at
95°C for 10 min and then cooled to 4°C. The rDNA
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the flanking 16S and 23S rDNA regions was amplified by
using the primers indicated in a previous paper [17] and a
Biometra (M-Medical SrL, Milan, Italy) thermocycler; the
amplified fragments were sequenced and aligned with the
most similar ones of GenBank using the Basic Local Align-
ment Search Tool (BLAST) program.
Evaluation of the gas-forming capability of the isolated
strains
The gas-forming capability of the strains isolated from
stool samples was assessed in Lauryl sulphate tryptose
broth containing lactose (10 g/L) as the sole carbon
source. After inoculum and incubation for 24-48 h at
37°C, bacterial cultures were examined for the presence
of gas bubbles in the medium [17]. Production of gas
indicated a positive reaction.
Lactobacillus strains and culture conditions
27 Lactobacillus strains belonging to 8 different species
were employed in this work and examined for their
anti-microbial activity against coliforms isolated from
colicky infants (Table 2). They were obtained from
American Type Culture Collection, Manassas, VA, USA
(referred to as ATCC strains), German Collection of
Microorganisms and Cell Cultures, Braunschweig, Ger-
many (referred to as DSM strains), National Collection
of Dairy Organisms, Reading, England (referred to as
NCDO strains) and from our collection (Department of
Pharmaceutical Sciences, University of Bologna, Italy
referred to as MB or S strains).
Assessment of the antagonistic activity
T h ea n t a g o n i s t i ca c t i v i t yo ft h es e l e c t e dLactobacillus
strains against the isolated coliforms was assayed by
using both agar plates and liquid co-cultures of both
strains.
- Antimicrobial activity on agar plates
In this assay both Lactobacillus spp. cells and Lactoba-
cillus neutralized cell-free supernatants (NCS) were
employed. Each Lactobacillus strain was grown in MRS
broth for 48 h at 37°C in 5% CO2 atmosphere and then
centrifuged at 15000 g at 4°C for 15 minutes. pH of the
cultures was neutralized to pH 7 with 1N NaOH and
cells were separated through filtration (via a 0.2 μm
pore size filter). Lactobacillus cells were washed twice
with saline and suspended in saline at concentrations
ranging from 10
4 to 10
6 CFU/ml. Lactobacillus cells
were washed twice with saline and suspended in saline
at concentrations of 10
4 ,1 0
5 and 10
6 CFU/ml. All the
cell suspensions were assayed to optimize the most sui-
table cell concentration; the cell concentration of 10
6
CFU/ml was then used to perform the comparative
assay of the inhibitory activity of the two Lactobacillus
strains against coliforms. The paper-disk assay of Kirby-
Bauer [23] was used with some modifications as follows.
50 μl of coliform liquid culture in LB broth containing
from 10
3 to 10
6 CFU/ml, in the majority of cases
between 10
5 and 10
6, was streaked on a Mac Conkey
and LB agar plate; subsequently two sterile paper blank
Table 1 Clinical characteristics of the study population and count of total coliforms bacteria
Colicky infants (n = 45) Controls (n = 42) p-value
Gender (M/F) 25/20 24/18 1.000**
Age at recruitment (days) 42 (15-95) 39 (17-98) 0.788*
Type of delivery (spontaneous/caesarean) 27/18 23/19 0.668**
Birth weight (grams) 3300 (2550-3970) 3350 (2520-4010) 0.951*
Crying time (minutes per day) 225 (185-310) 105 (60-135) 0.000*
Average count of total coliform bacteria (log10 CFU/g of faeces) 5.98 (2.00-8.76) 3.90 (2.50-7.10) 0.015*
Data are expressed as median (range) or numbers.
*Mann-Whitney Test.
**Fisher’s Exact Test
Table 2 Lactobacillus strains tested for their antagonist
activity against coliforms isolated from colicky infants
Lactobacillus
species
Strains
L. acidophilus ATCC 11975; MB 252; MB 253; MB 358; MB 359;
MB 422; MB 423; MB 424; MB 425; MB 442;
MB443
L. curvatus MB 67; MB 68
L. casei ATCC 393; MB 50; MB 441
L. delbrueckii subsp.
delbrueckii
DSM 20074
L. delbrueckii subsp.
lactis
DSM 20076
L. delbrueckii subsp.
bulgaricus
MB 453
L. salivarius subsp.
salicinius
ATCC 11742
L. salivarius subsp.
salivarius
ATCC 11741
L. gasseri MB 335
L. helveticus S 36.2; S40.8
L. plantarum ATCC 8014; NCDO 1193; MB 456
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and imbibed one with 50 μlo fw a s h e dLactobacillus
cells and the other with 50 μl of the corresponding
NCS. After incubation for 18 h at 37°C, the diameters of
the inhibition zones were evaluated. The experiments
were made in triplicate.
- Antimicrobial activity in liquid co-cultures
The capability of Lactobacillus DSM 20074 of interfer-
ing with the growth of coliforms was evaluated by co-
incubating both strains. The Lactobacillus strains and
the coliform strains were grown on MRS broth and LB
broth, respectively. The co-culture experiments was per-
formed in a modified LB medium (i.e. LB additioned
with 3% w/v yeast extract) capable of sustaining the
growth of both microorganisms. The medium was
inoculated with 10
5 CFU/ml of both the Lactobacillus
and the coliform strains and incubated at 37°C in micro-
aerophylic conditions. Controls were prepared by inocu-
lating the same medium either with the Lactobacillus
strain or with the coliform one; in addition coliforms
were co-cultured with a Lactobacillus strain with no
inhibition activity (L. casei MB50, Table 2). At 8-10 h
intervals, cultures were centrifuged for 15 min at 5000 g
and pellets were resuspended in fresh modified LB med-
ium to limit changes in growth due to pH variation or
nutrient limitation. 24 and 48 h after inoculation, bac-
terial cells were collected and thoroughly resuspended
by vortexing in phosphate-buffered saline (PBS). There-
after, Lactobacillus and coliform concentrations in the
co-cultures and in the controls was determined on MRS
agar plates additioned with vancomycin (0.2% w/v) and
MacConkey agar plates, which are selective for Lactoba-
cillus spp. and coliforms, respectively. Antimicrobial
activity was calculated by comparing the coliform
growth in the co-culture and control [8]. Results were
expressed as log10 CFU/ml. The experiment was per-
formed in triplicate.
Statistical Analyses
Sample size was calculated based on a difference
between groups of 1.5 log10 CFU/g faeces. Using a =
0.05, b = 0.20 and an estimated standard deviation
within groups of 2 log10 CFU/g faeces, 30 patients were
needed in each group. Counts (log10 CFU/g) of the
total amount of coliform bacteria were calculated for
each stool sample. Data are summarized by counts and
median and range for categorical and continuous vari-
ables respectively. Differences between groups were eval-
uated with Mann-Whitney’sU - t e s tf o rc o n t i n u o u s
variables, whereas associations between categorical vari-
ables were evaluated with Fisher’s exact test. Differences
between colicky infants and controls in total amount of
each species detected were evaluated with Mann-Whit-
ney’s test with Bonferroni correction. Statistical
significance was set at a p-value < 0.05. All statistical
calculations were performed with commercially available
software (SPSS for Windows release 15Æ0 SPSS Inc.,
Chicago, IL, USA).
Results
Isolation and identification of coliforms from colicky
infants
Coliform colonies were obtained on MacConkey agar
plates from faeces of all the 45 colicky infants and 42
controls. The average count of total coliforms in the 45
faecal samples of colicky infants was 5.98 (2.00-8.76)
log10 CFU/g of faeces, whereas total coliforms in the
control group were 3.90 (2.50-7.10) log10 CFU/g of
faeces. The difference between the two groups was sta-
tistically significant (p = 0.015). A total of 145 colonies
was randomly picked up from the higher dilutions agar
plates (10
-6-10
-8) and, only from colicky infants after
sub-culturing in LB agar, each purified strain was exam-
ined for gas production and characterized at species
level by DNA sequencing and carbohydrate fermenta-
tion profiling. All isolated strains were found to produce
gas from lactose according to the method described
above and the BBL™ Enterotube™ II system. They
were ascribed to six different species (Escherichia coli,
Klebsiella oxytoca, Klebsiella pneumoniae, Enterococcus
faecalis, Enterobacter aerogenes,a n dEnterobacter cloa-
cae), as described in Table 3. The percentage of detec-
tion of each species in the faecal samples examined was
reported in descending order (Table 3). The same taxo-
nomic identification was obtained with the two methods
employed.
Antimicrobial activity of lactic acid bacteria against
coliforms
One strain belonging to each species of isolated coli-
forms was selected in order to assess the antimicrobial
activity of the 27 Lactobacillus strains described in
Table 2. The coliform strains were referred to as E. coli
CG 15b, K. pneumoniae CG 23a, K. oxytoca CG Z, E.
aerogenes CG W,E. cloacae CG 6a and E. faecalis CG J.
Table 3 Identification of the strains isolated from faeces
of colicky infants at the species level and % of each
species of the total colonies isolated from the faeces
examined
Coliform identification Quantitative detection (%)
Escherichia coli 55.45
Klebsiella oxytoca 22.15
Klebsiella pneumoniae 12.34
Enterococcus faecalis 6.20
Enterobacter aerogenes 2.70
Enterobacter cloacae 2.50
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the agar plates method employing both the NCS and
washed cells. None of the NCS from all the Lactobacil-
lus strains was found to inhibit the growth of the coli-
form strains, whereas the washed cells of two strains, i.e.
L. delbrueckii subsp.delbrueckii DSM 20074 and L. plan-
tarum MB 456, were found to possess strong inhibitory
activity against all 6 coliforms as evidenced by the size
of the inhibition halo determined on the coliform plates
(Table 4). L. delbrueckii DSM 20074 exhibited a higher
anti-bacterial activity against all the coliforms than the
MB 456 strain. An example of the halo evidenced on
the coliform plates is presented for L. delbrueckii DSM
20074 (Figure 1).
The anti-microbial activity evaluation in liquid co-
cultures was performed with the Lactobacillus strain
showing the highest anti-microbial activity with the
previous method, i.e. L. delbrueckii subsp.delbrueckii
DSM 20074, and each of the strains referred to the six
species of coliform found. Inhibitory activity was evi-
denced against all the six coliform strains, being higher
with the E. coli CG 15b strain. Referring to the experi-
ment with DSM 20074 and E. coli CG 15b strains, the
co-culture at the beginning of the incubation time con-
tained 5.43 ± 0.54 log10 CFU/ml of L. delbrueckii DSM
20074 and 5.70 ± 0.35 log10 CFU/ml of E. coli CG 15b.
After 24 h of incubation, the DSM 20074 concentra-
tion was increased to 9.84 ± 0.94 log10 CFU/ml,
whereas no variations were observed in the E. coli
count. In the parallel control experiment, in which E.
coli was cultivated with no other strain, the E. coli
concentration was 5.65 ± 0.34 and 9.00 ± 1.00 log10
CFU/ml at the beginning of the incubation and after
24 hours, respectively. When E. coli was co-cultured
with L. casei MB50, no inhibition of E. coli growth was
observed. In the co-culture experiments performed
with L. delbrueckii DSM20074 and the other coliform
strains listed in Table 3, an inhibition of the coliform
growth of 3-4 log10 CFU/ml was observed (data not
shown). On the other hand, the growth of the Lactoba-
cillus strain was never influenced by co-cultivation
with the coliform strains.
Discussion
Different studies suggested that colonic gas production
favours infantile colic, however the speculation is not
supported by well-built scientific researches. Recently, it
has been evidenced that gas forming coliform concen-
tration is higher in colicky infants than in healthy con-
trols [16]. Various medical interventions have already
been applied to improve symptoms related to infantile
colic. Simethicone, a defoaming agent, has been pro-
moted as an effective treatment reducing the formation
of intraluminal gas, even though existing data do not
demonstrate conclusive benefit of such therapy [24,25].
A l t e r n a t i v es o l u t i o n st ot h ep r o b l e ma r et h e r e f o r e
looked forward.
Recently the benefit of supplementation with Lactoba-
cillus reuteri (American Type Culture Collection Strain
Table 4 Antagonistic activity of L. delbrueckii DSM 20074 and L. plantarum MB 456 cell suspensions (10
6 CFU/ml)
against coliforms isolated from colicky infants
Coliform strains Average diameter of the inhibition halo in mm (average ± SD)
L. delbrueckii DSM 20074 L. plantarum MB 456
E. coli CG 15b 10.23 ± 1.29 8.33 ± 0.89
K. oxytoca GC Y 9.75 ± 1.06 7.75 ± 0.76
K. pneumoniae CG 23a 9.83 ± 1.04 9.83 ± 0.64
E. faecalis GC W 10.16 ± 0.76 8.16 ± 0.56
E. aerogenes GC K 10.25 ± 0.65 7.25 ± 0.25
E. cloacae CG 6a 10.25 ± 0.35 7.05 ± 0.35
It has been expressed as average diameter of inhibition halos obtained on LB agar plates inoculated with each of the selected coliform strains
Figure 1 Inhibitory activity of L. delbrueckii DSM 20074 against
E. coli CG 15b. Upper paper disk was imbibed with 50 μlo fL.
delbrueckii washed cells, whereas bottom paper disk was imbibed
with 50 μl of neutralized supernatant of the same strain
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new therapeutic approach [14,15], even though clinical
trials are needed to promote new treatments to reduce
abdominal pain related to infantile colic [16].
Coliform growth and carbohydrate fermentation affect
ammonia absorption and urea nitrogen recycling and
excretion. We observed reduction in fecal ammonia
concentrations in breastfed infants given L. reuteri and
this could be related to modification of bacterial enzyme
activity depending on gut microbiota and suggested that
gas forming coliforms may be involved in determining
colonic fermentation and consequently excessive intrain-
testinal air load, aerophagia and pain, characteristic
symptoms of colic crying, but many aspects of these
relationships are still unclear [15]. In the present study
we confirmed the higher count of coliforms in colicky
infants with respect to non colicky newborns, as already
observed in a previous work [17].
Previous studies had shown that some Lactobacillus
spp. strains possessed inhibitory activity against E. coli,
preventing the binding of enteropathogenic E. coli and
other pathogens to intestinal cells [26]. More recently it
has been shown that a synbiotic diet containing both
prebiotics and probiotics reduces population of intest-
inal E. coli and the pathogen population in rats [27].
G i v e nt h e s ef i n d i n g s ,i nt h i sw o r kn e wLactobacillus
strains possessing anti-microbial activity against gas-pro-
ducing coliforms were searched and the interaction
between selected lactobacilli and coliforms was studied.
Coliforms were isolated from stools of colicky infants
and characterized taxonomically and for gas production.
They were all gas-producing strains and were attributed to
6 different species. The taxonomic identification of the
isolated strains and their relative percentage within the
coliform group confirmed the results obtained in a pre-
vious study, being E. coli the most represented species
[17]. Two of the 27 lactic acid bacteria assayed in this
study, L. delbrueckii subsp.delbrueckii DSM 20074 and L.
plantarum MB 456, were able to inhibit the growth of
gas-forming coliforms belonging to the different species
isolated from colicky infants. The extent of the inhibitory
activity was similar for all the coliforms assayed (Table 4),
although it was higher for the DSM 20074 strain with
respect to the other one. Moreover, the capability of the
DSM 20074 strain of hindering the growth of coliforms
was also observed in a liquid co-culturing assay. Therefore,
this strain appears to be a good candidate to relieve symp-
toms caused by gas-producing coliforms in colicky infants.
The antagonistic activity of the two Lactobacillus
strains was only evidenced when harvested cells were
applied, whereas the neutralized culture supernatants
did not exert any activity on the same coliforms (Figure
1). The inhibitory activity of lactic acid bacteria has gen-
erally been ascribed to two mechanisms, which can
often coexist: i) the production of bacteriocins or bacter-
iocin-like molecules, which are very often secreted out-
side the cell [28,29] and ii) the production of inhibitory
non proteinaceous metabolites such as organic acids,
carbon dioxide, ethanol, hydrogen peroxide and diacetyl,
whose anti-microbial action is well known [30]. In addi-
tion, Alakomi et al. reported that lactic acid can per-
meabilize the membrane of Gram negative bacteria by a
mechanism of outer membrane disruption [31]. In the
case of the two lactic acid bacteria showing inhibitory
activity against coliforms in this work, this activity is
linked to the presence of the whole cells, although it is
not possible to exclude that putative inhibitory mole-
cules are present in the supernatants at such a low con-
centration that their activity cannot be detected by the
assay employed. Therefore, it is not possible to clearly
ascribe the inhibitory activity to a defined group of
molecules and further studies are necessary to charac-
terize the exact mechanism of inhibition.
Conclusions
In conclusion, this study confirmed the presence of a
greater amount of coliforms in colicky infants with
respect to the controls, mainly belonging to the E. coli
species.
L. delbrueckii subsp.delbrueckii DSM 20074 strain
expressed potential for the inhibition of gas-producing
coliforms, and thus can be considered a promising can-
didate for the treatment of colicky symptoms in infants.
At present, few data are available on the role of probio-
t i c si nc o l i ca n dt h em e c h a n i s m sb yw h i c hp r o b i o t i c
bacterial strains antagonise pathogenic gastrointestinal
microorganisms or exert other beneficial effects in vivo
have not yet been fully defined. Even so, there is a grow-
ing interest within clinical medicine in the understand-
ing of the mechanisms through which lactic acid
bacteria exert their antagonistic activity against patho-
gens in the gut. Finally, clinical investigations about in-
vivo efficacy are necessary to confirm the role of Lacto-
bacillus s t r a i n sa se f f i c a c i o u sp r o b i o t i ct r e a t m e n tt o
modulate the colonic microbiota in newborns and
improve abdominal discomfort due to infantile colic.
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